98%
921
2 minutes
20
Introduction: Clinical scores based on signs and symptoms have been used in thyroidology to identify individuals at high risk for hypothyroidism. The current study observes the signs and symptoms of patients with hypothyroidism who are positive for hypothyroidism according to the Zulewski clinical score, and determines associations between thyroid and lipid profiles.
Methods: The current prospective cohort study was conducted among newly diagnosed hypothyroid patients aged 18-65 years with a Zulewski score > 5 (indicative of hypothyroidism) and biochemically diagnosed as hypothyroid. Demographics, thyroid, and lipid profiles of the patients were recorded and analysed. A P < 0.05 was considered to be statistically significant.
Results: The current study included 100 patients with hypothyroidism (M:F = 1:1.94), with an average age of 40.9 ± 12.1 years. Slow movement and coarse skin were the most common signs among men (67.6%) and women (68.2%), respectively. Weight gain was the most common symptom (M: 91.2%; F: 87.9%). The TSH levels of patients significantly increased with higher Zulewski scores. A deranged lipid profile was observed in 86% of patients. A positive correlation was observed between total cholesterol and TSH (r = 0.275; P = 0.006), and between total cholesterol and T4 (r = -0.205; P = 0.041). A negative correlation was observed between T3 and cholesterol (r = -0.263; P = 0.008), and between T3 and triglycerides (r = -0.263; P = 0.008).
Conclusion: The current study highlights the reliability of the Zulewski score for early diagnosis and risk assessment in Indian patients with hypothyroidism. It could also serve as an indirect clinical measure to assess deranged lipid parameters and identify the risk of atherosclerosis among hypothyroid patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12359284 | PMC |
http://dx.doi.org/10.7759/cureus.88288 | DOI Listing |
Front Oncol
August 2025
Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Background: Immune checkpoint inhibitors (ICIs) are effective against solid tumors but can trigger immune-related adverse events (irAEs), including adrenal insufficiency (AI). Given its impact on treatment efficacy and patient quality of life, understanding the clinical characteristics and outcomes of ICI-induced AI (ICI-AI) is critical.
Methods: We conducted a retrospective analysis of 46 patients diagnosed with ICI-AI at a single center (May 2019-July 2024) and reviewed clinical trials/real-world studies on ICI-AI.
Indian J Endocrinol Metab
August 2025
Department of Endocrinology and Diabetes, Bangalore Endocrinology and Diabetes Research Centre, Bengaluru, Karnataka, India.
The management of hypothyroidism is based on the assumption that levothyroxine monotherapy normalizes thyroid hormone homeostasis, rendering patients clinically and biochemically euthyroid. However, a subset of patients treated with levothyroxine (LT4) are dissatisfied as they continue to have symptoms such as fatigue, weight gain, and difficulty in concentration. Some patients do not achieve normalization of thyroid-stimulating hormone despite adherence to adequate LT4 dosing.
View Article and Find Full Text PDFIndian J Endocrinol Metab
August 2025
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College Vellore, Vellore, Tamil Nadu, India.
Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy by enhancing T-cell-mediated tumour eradication. However, their use is associated with immune-related adverse events, with endocrinopathies being the most common. Thyroid dysfunction, hypophysitis, primary adrenal insufficiency (PAI), and insulin-dependent diabetes mellitus are well-documented complications.
View Article and Find Full Text PDFThyroid
September 2025
Department of Molecular Diagnostics, Department of Endocrinology, The Core Laboratory in Medical Center of Clinical Research, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
is a major cause of congenital hypothyroidism (CH) in Chinese patients, but clinical outcomes for those with biallelic mutations remain unclear. This study aimed to describe the clinical manifestations of CH due to defect. One hundred eighty-one patients with primary CH were recruited initially and were subjected to genetic screening.
View Article and Find Full Text PDFAuris Nasus Larynx
September 2025
Department of Otolaryngology, Tenri Hospital, Tenri, Nara, Japan.
Objective: This study aimed to identify prognostic factors for postoperative hypothyroidism and assess the timing of its onset in patients who underwent hemithyroidectomy for thyroid tumors. Despite normal preoperative thyroid function, some patients develop postoperative hypothyroidism, necessitating lifelong thyroid hormone replacement therapy. Identifying risk factors and establishing appropriate follow-up guidelines are essential for optimizing patient management.
View Article and Find Full Text PDF